MEMBRANOUS NEPHROPATHY
Clinical trials for MEMBRANOUS NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new MEMBRANOUS NEPHROPATHY trials appear
Sign up with your email to follow new studies for MEMBRANOUS NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized interferon therapy aims to tame kidney disease without weakening defenses
Disease control TerminatedThis phase 2 trial investigates whether a personalized course of peginterferon alfa-2a can control membranous nephropathy, an autoimmune kidney disease. The treatment targets the Th17 inflammatory pathway, which is linked to a higher risk of relapse. Participants receive injectio…
Matched conditions: MEMBRANOUS NEPHROPATHY
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Kidney disease drug trial halted early after only 6 patients
Disease control TerminatedThis early-stage study tested a new drug called VB119 in 6 adults with primary membranous nephropathy, a kidney disease. The main goal was to check safety and how the body handles the drug, not to cure the disease. The study was terminated early, so results are limited.
Matched conditions: MEMBRANOUS NEPHROPATHY
Phase: PHASE1, PHASE2 • Sponsor: Tenet Medicines • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC